Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01614340 · ClinicalTrials.gov registry record · NA

Treating Pain to Reduce Disability Among Older Home Health Patients

A NA study, sponsored by Visiting Nurse Service of New York.

Completed
Registry status
NA
Development phase
658
Enrollment target

NCT01614340: Completed NA study, sponsored by Visiting Nurse Service of New York.

NCT01614340 is a NA study that has completed, run by Visiting Nurse Service of New York. The registered enrollment target is 658 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01614340, a NA study, has completed, sponsored by Visiting Nurse Service of New York.

COMPLETED
Registry status
NA
Development phase
658 participants
Enrollment target

Study Summary

The overall goal of this real-world comparative effectiveness research (CER) study is to reduce disability among older home health patients by treating their pain more effectively. To achieve this goal the investigators will conduct a cluster randomized controlled trial of a physical therapist (PT) delivered intervention provided to VNSNY home health care patients with activity-limiting pain. The intervention is an evidence-based non-pharmacological program to reduce pain and pain-related disability that utilizes cognitive-behavioral pain self-management (CBPSM) techniques.

Primary Outcome

Patients receiving usual care plus the intervention when compared with participants receiving usual care only will demonstrate (1) Significantly better results as measured by the Timed Up and Go test; Timed Chair Stands, and Timed Foot Taps test;(2) Significantly better ADL functioning;(3) Significantly reduced levels of pain-related disability as measured by the Roland Morris Disability Questionnaire; and (4) Significantly reduced levels of pain intensity and increased levels of pain relief as

Interventions

  • BEHAVIORAL Cognitive-Behavioral Pain Self-management Program

Trial Details

FieldValue
Enrollment Target 658 participants
Start Date 2012-10
Est. Completion 2015-12
Phase NA

What the finished NCT01614340 record still lists

NCT01614340 is an interventional study that assigns participants to a tested intervention. The registered 658 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (53% lower).

The record links to 0 conditions, and to 1 intervention - of which Cognitive-Behavioral Pain Self-management Program is the first listed.

NCT01614340 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01614340 about?

NCT01614340 is a clinical study titled "Treating Pain to Reduce Disability Among Older Home Health Patients". The overall goal of this real-world comparative effectiveness research (CER) study is to reduce disability among older home health patients by treating their pain more effectively. To achieve this goal the investigators will conduct a cluster randomized controlled trial of a physical therapist (PT) ...

What is the current status of trial NCT01614340?

This trial is currently completed. It is a NA study. The enrollment target is 658 participants. The study started on 2012-10. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01614340?

The interventions under investigation include: Cognitive-Behavioral Pain Self-management Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT01614340?

This trial is sponsored by Visiting Nurse Service of New York, which has 4 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01614340's enrollment target sits among peer trials

658 156th of 2000 higher than 1,845 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07216742 · 659 participants · Phase 3

    Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

  • NCT03671044 · 657 participants · Phase 3

    A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

  • NCT05338697 · 657 participants

    Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials

  • NCT01185132 · 660 participants · Phase 3

    Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01614340, the US trial registry maintained by the National Library of Medicine. NCT01614340 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.